EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation

Di Lu, Gulibositan Aji, Guanyu Li, Yue Li, Wenlin Fang, Shuai Zhang, Ruiqi Yu, Sheng Jiang, Xia Gao, Yuhang Jiang, Qi Wang

Journal of Clinical Investigation · 17.03.2025 · 135 (6)

DOI: 10.1172/jci180242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 04.02.2025. Verfasst von Di Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Lipoylation, Proto-Oncogene Proteins p21(ras), Acyltransferases, Kidney. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Initiation Fund of Qingyuan People’s Hospital, Xinjiang Uygur Autonomous Region Human Resources and Social Security Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis is the final common pathway leading to end-stage chronic kidney disease (CKD). However, the function of protein palmitoylation in renal fibrosis and the underlying mechanisms remain unclear. In this study, we observed that expression of the palmitoyltransferase ZDHHC18 was significantly elevated in unilateral ureteral obstruction (UUO) and folic acid–induced (FA-induced) renal fibrosis mouse models and was significantly upregulated in fibrotic kidneys of patients with CKD. Functionally, tubule-specific deletion of ZDHHC18 attenuated tubular epithelial cells’ partial epithelial-mesenchymal transition (EMT) and then reduced the production of profibrotic cytokines and alleviated tubulointerstitial fibrosis. In contrast, ZDHHC18 overexpression exacerbated progressive renal fibrosis. Mechanistically, ZDHHC18 catalyzed the palmitoylation of HRAS, which was pivotal for its translocation to the plasma membrane and subsequent activation. HRAS palmitoylation promoted downstream phosphorylation of MEK/ERK and further activated Ras-responsive element–binding protein 1 (RREB1), enhancing SMAD binding to the Snai1 cis -regulatory regions. Taken together, our findings suggest that ZDHHC18 plays a crucial role in renal fibrogenesis and represents a potential therapeutic target for combating kidney fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoylationProto-Oncogene Proteins p21(ras)AcyltransferasesKidneyRenal Insufficiency, ChronicAnimalsHumansMiceFibrosisEpithelial-Mesenchymal TransitionMaleMice, KnockoutMAP Kinase Signaling System

Stichwörter der Autor:innen

FibrosisNephrologyTherapeutics

Substanzen

Proto-Oncogene Proteins p21(ras)AcyltransferasesHras protein, mouseHRAS protein, human

Autor:innen und Institutionen

  • Nephrology Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Department of Endocrinology, The First Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China.
  • Department of Pediatrics, Jiangxi Children's Medical Center, Nanchang, China.
  • State Key Laboratory of Genetic Engineering, School of Life Sciences and Zhongshan Hospital, Fudan University, Shanghai, China.
  • The Key Laboratory of Experimental Teratology of the Ministry of Education and Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Department of Orthopedics, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Förderung

  • Postdoctoral Initiation Fund of Qingyuan People’s Hospital
  • Xinjiang Uygur Autonomous Region Human Resources and Social Security Department

Zitieren

APA

Lu, D., Aji, G., Li, G., Li, Y., Fang, W., Zhang, S., Yu, R., Jiang, S., Gao, X., Jiang, Y., & Wang, Q. (2025). ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation. Journal of Clinical Investigation, 135(6). https://doi.org/10.1172/jci180242

Vancouver

Lu D, Aji G, Li G, Li Y, Fang W, Zhang S, et al. ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation. Journal of Clinical Investigation. 2025;135(6). doi:10.1172/jci180242

BibTeX
@article{Lu2025,
  author = {Lu, Di and Aji, Gulibositan and Li, Guanyu and Li, Yue and Fang, Wenlin and Zhang, Shuai and Yu, Ruiqi and Jiang, Sheng and Gao, Xia and Jiang, Yuhang and Wang, Qi},
  title = {ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {6},
  doi = {10.1172/jci180242}
}
Kostenlos starten →